Загрузка видео...

Не удалось загрузить видео

На главную

Looking for ivermectin from a licensed U.S. pharmacy? Dr. William Makis discusses ivermectin, mebendazole, and the growing interest in repurposed medications. - Human-grade ivermectin - Multiple strengths available - Licensed provider review - Shipped directly to your door

4,182,513 просмотров • 1 месяц назад •via X (Twitter)

Комментарии: 0

Нет доступных комментариев

Здесь появятся комментарии из оригинального поста

Похожие видео

🚨 “THE BEST RESULTS I’VE SEEN.” DR. WILLIAM MAKIS & DR. JOHN CAMPBELL DISCUSS IVERMECTIN + CHEMOTHERAPY FOR CANCER What happens when Dr. John Campbell asks Dr. William Makis to get specific about Ivermectin and cancer? The conversation quickly moves from theory to dose, timeline, cancer markers, imaging, and patient outcomes. 💊 WHERE DOES MAKIS START? Makis says the Ivermectin dose he discusses for intermediate to high-grade cancers starts around: 📌 1 mg/kg/day For lower-grade cancers, he says he starts lower, around: 📌 0.5 mg/kg/day He gives examples including CLL and multiple myeloma. 📅 WHY DOES HE TALK ABOUT 3 MONTHS? Makis says he suggests assessing Ivermectin use over approximately 3 months, followed by reassessment using: 🧪 Blood work 📊 Cancer markers 🩻 Follow-up imaging According to him, some changes in cancer markers can appear within 3–4 weeks. He specifically mentions: • PSA • CEA • CA-125 🩻 THEN COMES THE IMAGING Makis says tumor activity may begin changing on a PET scan in about a month. But physically seeing tumors or lymph nodes shrink can take longer. He says changes may begin appearing on: MRI → PET-CT → CT over approximately 2–3 months. 👀 THEN CAMPBELL ASKS ABOUT HIS MOST DRAMATIC RESULTS Makis' answer is the part that stands out: “The best results I’ve seen in my patients are patients who are doing a combination of chemotherapy and ivermectin.” 🔥 IVERMECTIN IS THE DETAIL THAT STANDS OUT. Makis says the best results he's seen have involved patients using Ivermectin alongside chemotherapy. That makes the question even more interesting: "Could Ivermectin have a larger role in cancer research than we currently understand?" ❓ THE BIGGER REPURPOSED-MEDICINE QUESTION This conversation puts Ivermectin + chemotherapy into a much bigger discussion about drug repurposing in cancer. What makes repurposed medicines so interesting? 💊 Existing medicines 🧬 Multiple biological pathways 🔬 New applications being investigated 📊 Different cancer types ⚡ Potential combination strategies And Ivermectin isn't the only repurposed medicine attracting attention. Fenbendazole. Mebendazole. Metformin. Doxycycline. Statins. Different medicines. Different mechanisms. But one common question: Could medicines we already have be hiding new possibilities in cancer research? THAT'S THE CONVERSATION WORTH WATCHING. 📌 SAVE this discussion for the next repurposed-medicine breakdown. 🔄️ REPOST if you think existing medicines deserve a second look in cancer research. 💊 Looking for Ivermectin or other repurposed medicines? Explore available options at RXMEDS.STORE with worldwide delivery. #Ivermectin #CancerResearch #Chemotherapy #Cancer #DrWilliamMakis #DrJohnCampbell #RepurposedMedicine #MedicalResearch

RXMEDS.STORE

27,420 просмотров • 1 месяц назад

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,292,906 просмотров • 1 год назад

🚨 “MY ONCOLOGIST IS SHOCKED.” DR. WILLIAM MAKIS ON FENBENDAZOLE, STAGE 4 CANCER & REPURPOSED DRUGS What happens when patients who had already gone through multiple lines of chemotherapy start coming back with a very different story? According to Dr. William Makis, this is what caught his attention. He discusses Fenbendazole, Mebendazole and other repurposed drugs in the context of difficult Stage 4 cancers, including patient experiences he says he encountered repeatedly. 🔥 The story that started it Makis discusses Joe Tippens, who was diagnosed with Stage 4 small cell lung cancer, an aggressive form of cancer. According to Makis, Tippens received a less than 1% five year survival estimate. He was placed on Keytruda, an immune checkpoint inhibitor. Then came Fenbendazole. Makis says Tippens later reported becoming cancer free and remaining so years later. That less than 1% survival estimate is what makes the story so striking, and it became one of the stories that pushed Makis to look more closely at repurposed medicines and cancer research. 🧬 Then Makis looked at the research Makis says there is a growing body of preclinical research on Fenbendazole. He also discusses published cases involving patients with advanced cancer who had previously failed multiple chemotherapy regimens. According to Makis, these patients subsequently experienced major improvements after using Fenbendazole. 📈 And then the patient stories kept coming Makis describes patients returning to him saying: “My cancers are shrinking.” He says some told him their oncologists were shocked by what they were seeing. He describes reports involving: • Stage 4 pancreatic cancer • Cholangiocarcinoma • Ovarian cancer • Small cell lung cancer He also discusses patients whose tumors reportedly shrank despite having already failed multiple lines of chemotherapy. 💊 The bigger conversation This is where Makis connects Fenbendazole, Mebendazole, Ivermectin and other repurposed medicines to a broader cancer research discussion. His argument is that existing medicines deserve serious investigation for potential applications beyond their original indications. And his final message is especially striking: “I think repurposed drugs can give patients hope in situations that are very dire.” That is the bigger question behind the conversation: How many existing medicines could have unexplored potential in cancer research? The stories are fueling growing interest in Fenbendazole, Mebendazole, Ivermectin and drug repurposing, and that conversation is becoming increasingly difficult to ignore. 📌 SAVE this breakdown for the Fenbendazole and repurposed medicine discussion. 🔄 REPOST if you think overlooked medicines deserve more serious cancer research. 💊 Looking for Fenbendazole or Mebendazole? Find repurposed drugs at RXMEDS.STORE with worldwide delivery. #Fenbendazole #Mebendazole #Ivermectin #CancerResearch #Stage4Cancer #RepurposedDrugs #Oncology #CancerResearch

RXMEDS.STORE

28,795 просмотров • 1 месяц назад

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS | BUY IVERMECTIN,MEBENDAZOLE AND MORE for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

GENIX MEDS | BUY IVERMECTIN,MEBENDAZOLE AND MORE

20,450 просмотров • 4 месяцев назад